Treatment of chancroid in resource-poor countries

References

• Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75, 3–17 (1999).
   PubMed Web of Science ®Google Scholar
• Behets FM, Brathwaite AR, Hylton-Kong T et al. Genital ulcers: etiology, clinical diagnosis and human immunodeficiency virus infection in Kingston, Jamaica. Clin. Infect. Dis. 28, 1086–1090 (1999).
   PubMedGoogle Scholar
• Latif AS, Katzenstein DA, Bassett MT, Houston S, Emmanuel JC, Marowa E. Genital ulcers and transmission of HIV among couples in Zimbabwe. AIDS 3(8), 519–523 (1989).
   PubMed Web of Science ®Google Scholar
• Plummer FA, Simonsen JN, Cameron DW et al. Cofactors in male–female sexual transmission of human immunodeficiency virus Type 1. J. Infect. Dis. 163, 233–239 (1991).
   PubMed Web of Science ®Google Scholar
• Lewis DA. Chancroid: clinical manifestations, diagnosis and management. Sex. Transm. Infect. 79, 68–71 (2003).
   PubMed Web of Science ®Google Scholar
• Sehgal VN, Srivastava G. Chancroid: contemporary appraisal. Int. J. Dermatol. 42, 182–190 (2003).
   PubMedGoogle Scholar
• Ndinya-Achola JO, Kihara AN, Fisher LD et al. Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary healthcare setting in Nairobi. Int. J. STD AIDS 7, 201–205 (1996).
   PubMedGoogle Scholar
• Chapel TA, Brown WJ, Jeffres C, Stewart JA. How reliable is the morphological diagnosis of penile ulcerations? Sex. Transm. Dis. 4(4), 150–152 (1977).
   PubMed Web of Science ®Google Scholar
• Dangor Y, Ballard RC, Exposto F, Fehler G, Miller SD, Koornhof HJ. Accuracy of clinical diagnosis of genital ulcer disease. Sex. Transm. Dis. 17, 184–189 (1990).
   PubMedGoogle Scholar
• O’Farrell N, Hoosen AA, Coetzee KD, van den Ende J. Genital ulcer disease: accuracy of clinical diagnosis and strategies to improve control in Durban, South Africa. Genitourinary Med. 70(1), 7–11 (1994).
   PubMedGoogle Scholar
• Morse SA. Chancroid and Haemophilus ducreyi. Clin. Microbiol. Rev. 2, 137–157 (1989).
   PubMed Web of Science ®Google Scholar
• Lewis DA. Chancroid: from clinical practice to basic science. AIDS Patient Care STDs 14, 19–36 (2000).
   PubMedGoogle Scholar
• Spinola SM, Wild LM, Apicella MA, Gaspari AA, Campagnari AA. Experimental human infection with Haemophilus ducreyi. J. Infect. Dis. 169, 1146–1150 (1994).
   PubMedGoogle Scholar
• Al-Tawfiq JA, Thornton AC, Katz BP et al. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J. Infect. Dis. 178(6), 1684–1687 (1998).
   PubMedGoogle Scholar
• Humphreys TL, Schnizlein-Bick CT, Katz BP et al. Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J. Immunol. 169(11), 6316–6323 (2002).
   PubMedGoogle Scholar
• King R, Gough A, Nasio J, Ndinya-Achola F, Plummer F, Wilkins J. An immunohistochemical analysis of naturally occurring chancroid. J. Infect. Dis. 174, 427–430 (1996).
   PubMedGoogle Scholar
• Ortiz-Zepeda C, Hernandez-Perez E, Marroquin-Burgos R. Gross and microscopic features in chancroid: a study in 200 new culture-proven cases in San Salvador. Sex. Transm. Dis. 21, 112–117 (1994).
   PubMedGoogle Scholar
• Trees DL, Morse SA. Chancroid and Haemophilus ducreyi: an update. Clin. Microbiol. Rev. 8, 357–375 (1995).
   PubMed Web of Science ®Google Scholar
• Sehgal VN, Shyam Prasad AL. Chancroid or chancroidal ulcer. Dermatologica 170, 136–141 (1985).
   PubMedGoogle Scholar
• Bruisten SM. Genital ulcers in women. Curr. Womens Health Rep. 3, 288–298 (2003).
   PubMedGoogle Scholar
• Bong CT, Harezlak J, Katz BP, Spinola SM. Men are more susceptible than women to pustule formation in the experimental model of Haemophilus ducreyi infection. Sex. Transm. Dis. 29, 114–118 (2002).
   PubMedGoogle Scholar
• Ronald AR, Albritton W. Chancroid and Haemophilus ducreyi. In: Sexually Transmitted Diseases, Third Edition. Holmes K, Sparling PF, Mardh P-A et al. (Eds). McGraw-Hill, NY, USA, 515–523 (1999).
   Google Scholar
• O’Farrell N, Egger M. Circumcision in men and the prevention of HIV infection: a ‘meta-analysis’ revisited. Int. J. STD AIDS 11(3), 137–142 (2000).
   PubMed Web of Science ®Google Scholar
• Tyndall MW, Ronald AR, Agoki E et al. Increased risk of infection with human immunodeficiency virus Type 1 among uncircumcised men presenting with genital ulcer disease in Kenya. Clin. Infect. Dis. 23(3), 449–453 (1996).
   PubMed Web of Science ®Google Scholar
• Nasio JM, Nagelkerke NJD, Mwatha A, Moses S, Ndinya-Achola JO, Plummer FA. Genital ulcer disease among STD attenders in Nairobi: association with HIV-1 and circumcision status. Int. J. STD AIDS 7(6), 410–414 (1996).
   PubMed Web of Science ®Google Scholar
• Hammond GW, Slutchuk M, Scatliff J, Sherman E, Wilt JC, Ronald AR. Epidemiological, clinical laboratory and therapeutic features of an urban outbreak of chancroid in North America. Rev. Inf. Dis. 2(6), 867–879 (1980).
   PubMedGoogle Scholar
• Bruisten SM, Cairo I, Fennema H et al. Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands. J. Clin. Microbiol. 39(2), 601–605 (2001).
   PubMedGoogle Scholar
• Totten PA, Kuypers JM, Chen C-Y et al. Etiology of genital ulcer disease in Dakar, Senegal and comparison of PCR and serologic assays for detection of Haemophilus ducreyi. J. Clin. Microbiol. 38(1), 268–273 (2000).
   PubMedGoogle Scholar
• Behets FM, Andriamiadana J, Randrianasolo D et al. Chancroid, primary syphilis, genital herpes and lymphogranuloma venereum in Antananarivo, Madagascar. J. Infect. Dis. 180, 1382–1385 (1999).
   PubMedGoogle Scholar
• Lai W, Chen CY, Morse SA et al. Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sex. Transm. Dis. 79(3), 202–207 (2003).
   Google Scholar
• Kimani J, Bwayo JJ, Anzala AO et al. Low dose Erythromycin regimen for the treatment of chancroid. East Afr. Med. J. 72, 645–648 (1995).
   PubMedGoogle Scholar
• Thomas DL, Quinn TC. Serologic testing for sexually transmitted diseases. Infect. Dis. Clin. N. Am. 4, 793–823 (1993).
   Google Scholar
• Dada AJ, Ajayi AO, Diamondstone L, Quinn TC, Blattner WA, Biggar RJ. A Serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos, Nigeria. Sex. Transm. Dis. 25(5), 237–242 (1998).
   PubMed Web of Science ®Google Scholar
• Risbud A, Chan-Tack K, Gadkari D et al. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex. Transm. Dis. 26(1), 55–62 (1999).
   PubMedGoogle Scholar
• Dicarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin. Infect. Dis. 25, 292–298 (1997).
   PubMedGoogle Scholar
• Htun Y, Morse SA, Dangor Y et al. Comparison of clinically directed, disease specific and syndromic protocols for the management of genital ulcer disease in Lesotho. Sex. Transm. Infect. 74(Suppl. 1), S23–S28 (1998).
   Google Scholar
• Bogaerts J, Kestens L, van-Dyck E, Tello WM, Akingeneye J, Mukantabana V. Genital ulcers in a primary health clinic in Rwanda: impact of HIV infection on diagnosis and ulcer healing (1986–1992). Int. J. STD AIDS 9(11), 706–710 (1998).
   PubMedGoogle Scholar
• Sanchez J, Volquez C, Totten PA et al. Etiology and management of genital ulcers in the Dominican Republic and Peru. Sex. Transm. Dis. 29(10), 559–567 (2002).
   PubMed Web of Science ®Google Scholar
• Lewis DA. Diagnostic tests for chancroid. Sex. Transm. Dis. 76, 137–141 (2000).
   Google Scholar
• Orle KA, Gates CA, Martin DH, Body BA, Weiss JB. Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum and herpes simplex virus types 1 and 2 from genital ulcers. J. Clin. Microbiol. 34, 49–54 (1996).
   PubMed Web of Science ®Google Scholar
• Morse SA, Trees DL, Htun Y et al. Comparison of clinical diagnosis and standard laboratory and molecular methods for the diagnosis of genital ulcer disease in Lesotho: association with human immunodeficiency virus infection. J. Infect. Dis. 175, 583–589 (1997).
   PubMed Web of Science ®Google Scholar
• Pépin J, Mabey D. Sexually transmitted infections in Africa: single-dose treatment is now affordable. Sex. Transm. Infect. 79, 432–434 (2003).
   PubMedGoogle Scholar
• Malonza IM, Tyndall MW, Ndinya-Achola JO et al. A randomized, double-blind, placebo-controlled trial of single-dose ciprofloxacin versus erythromycin for the treatment of chancroid in Nairobi, Kenya. J. Infect. Dis. 180(6), 1886–1893 (1999).
   PubMedGoogle Scholar
• Chen CY, Ballard RC, Beck-Sague CM et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa. Sex. Transm. Dis. 27(1), 21–29 (2000).
   PubMed Web of Science ®Google Scholar
• Tyndall MW, Plourde PJ, Agoki E et al. Fleroxacin in the treatment of chancroid: an open study in men seropositive or seronegative for the human immunodeficiency virus Type 1. Am. J. Med. 94(3A), S85–S88 (1993).
   Google Scholar
• MacDonald KS, Cameron DW, D’Costa LJ, Ndinya-Achola JO, Plummer FA, Ronald AR. Evaluation of Fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya. Antimicrob. Agents Chemother. 33(5), 612–614 (1989).
   PubMed Web of Science ®Google Scholar
• Tyndall M, Malisa M, Plummer FA, Ombetti J, Ndinya-Achola JO, Ronald AR. Ceftriaxone no longer predictably cures chancroid in Kenya. J. Infect. Dis. 167, 469–471 (1993).
   PubMedGoogle Scholar
• Tyndall MW, Agoki E, Plummer FA, Malisa W, Ndinya-Achola JO, Ronald AR. Single dose azithromycin for the treatment of chancroid: a randomized comparison with erythromycin. Sex. Transm. Dis. 21(4), 231–234 (1994).
   PubMedGoogle Scholar
• Bowmer MI, Nsanze H, D’Costa LJ et al. Single-dose ceftriaxone for chancroid. Antimicrob. Agents Chemother. 31(1), 67–69 (1987).
   PubMed Web of Science ®Google Scholar
• Moodley P, Sturm PD, Vanmali T, Wilkinson D, Connolly C, Sturm AW. Association between HIV-1 infection, the etiology of genital ulcer disease, and response to syndromic management. Sex. Transm. Dis. 30, 241–245 (2003).
   PubMed Web of Science ®Google Scholar
• Schmid GP. Treatment of chancroid, 1989. Rev. Infect. Dis. 12(Suppl. 6), S580–S589 (1990).
   Google Scholar
• Viravan C, Dance DAB, Ariyarit C et al. A prospective clinical and bacteriologic study of inguinal buboes in Thai men. Clin. Infect. Dis. 22, 233–239 (1996).
   PubMedGoogle Scholar
• Ernst AA, Marvez-Valls E, Martin DH. Incision and drainage versus aspiration of fluctuant buboes in the emergency department during an epidemic of chancroid. Sex. Transm. Dis. 22(4), 217–220 (1995).
   PubMedGoogle Scholar
• Knapp JS, Back AF, Babst AF, Taylor D, Rice RJ. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob. Agents Chemother. 37(7), 1552–1555 (1993).
   PubMedGoogle Scholar
• Behets FM, Liomba G, Lule G et al. Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. J. Infect. Dis. 171(2), 451–455 (1995).
   PubMedGoogle Scholar
• D’Souza P, Pandhi RK, Khanna N, Rattan A, Misra RS. A comparative study of therapeutic response of patients with clinical chancroid to ciprofloxacin, erythromycin and cotrimoxazole. Sex. Transm. Dis. 25(6), 293–295 (1998).
   PubMedGoogle Scholar
• Bogaerts J, Kestens L, Tello WM et al. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to Trimethoprim–sulfamethoxazole. Clin. Infect. Dis. 20, 924–930 (1995).
   PubMedGoogle Scholar
• Ballard RC, Radebe F. A comparison of ofloxacin and ciprofloxacin in the treatment of chancroid. 10th Meeting of the International Society for Sexually Transmitted Diseases. Helsinki, Finland, 29 August–1 September 1993 (Abstract 116).
   Google Scholar
• Bodhidatta L, Taylor DN, Chitwarakorn A, Kuvanont K, Echeverria P. Evaluation of 500 and 1000 mg doses of ciprofloxacin for the treatment of chancroid. Antimicrob. Agents Chemother. 32(5), 723–725 (1988).
   PubMedGoogle Scholar
• Plourde PJ, D’Costa LJ, Agoki E et al. A randomized, double-blind study of the efficacy of fleroxacin versus trimethoprim–sulfamethoxazole in men with culture-proven chancroid. J. Infect. Dis. 165, 949–952 (1992).
   PubMedGoogle Scholar
• Duncan MO, Bilgeri YR, Fehler HG, Ballard RC. Treatment of chancroid with erythromycin: clinical and microbiological appraisal. Br. J. Vener. Dis. 59(4), 265–268 (1983).
   PubMedGoogle Scholar
• Martin DH, Sargent SJ, Wendel GD Jr, McCormack WM, Spier NA, Johnson RB. Comparison of azithromycin and ceftriaxone for the treatment of chancroid. Clin. Infect. Dis. 21, 409–414 (1995).
   PubMedGoogle Scholar
• Thornton AC, O’Mara EM Jr, Sorensen SJ et al. Prevention of experimental Haemophilus ducreyi infection: a randomized controlled clinical trial. J. Infect. Dis. 177, 1608–1613 (1998)
   PubMedGoogle Scholar
• Steen R,Vuylsteke B, DeCoito T et al. Evidence of declining STD prevalence in a South African mining community following a core group intervention. Sex. Transm. Dis. 27, 1–8 (2000).
   PubMed Web of Science ®Google Scholar
• Taylor DN, Pitarangsi C, Echeverria P, Panikabutra K, Suvongse C. Comparative study of ceftriaxone and trimethoprim–sulfamethoxazole for the treatment of chancroid in Thailand. J. Infect. Dis. 152(5), 1002–1006 (1985).
   PubMed Web of Science ®Google Scholar
• Van-Dyck E, Bogaerts J, Smet H, Tello WM, Mukantabana V, Piot P. Emergence of Haemophilus ducreyi resistance to trimethoprim–sulfamethoxazole in Rwanda. Antimicrob. Agents Chemother. 38(7), 1647–1648 (1994).
   PubMedGoogle Scholar
• Rajan VS, Sng EH, Lim AL. The isolation of H. ducreyi in Singapore. Am. Acad. Med. Singapore 12, 57–60 (1983).
   PubMedGoogle Scholar
• Albritton WL, MacLean IW, Slaney LA, Ronald AR, Deneer HG. Plasmid-mediated tetracycline resistance in Haemophilus ducreyi. Antimicrob. Agents Chemother. 25(2), 187–190 (1984).
   PubMed Web of Science ®Google Scholar
• Latif AS. Thiamphenicol in the treatment of chancroid in men. Br. J. Vener. Dis. 58, 54–55 (1982).
   PubMedGoogle Scholar
• Latif AS, Crocchiolo PR, Lencioni R. Thiamphenicol in the treatment of chancroid in men. Sex. Transm. Dis. 11(4S), 454–455 (1984).
   PubMedGoogle Scholar
• Belda Junior W, Siqueira LF, Fagundes LJ. Thiamphenicol in the treatment of chancroid. A study of 1128 cases. Rev. Inst. Med. Trop. S. Paula 42(3), 133–135 (2000).
   PubMedGoogle Scholar
• Abeck D, Johnson AP, Dangor Y, Ballard RC. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa. J. Antimicrob. Chemother. 22, 437–444 (1988).
   PubMedGoogle Scholar
• Sarafian SK, Knapp JS. Molecular epidemiology based on plasmid profiles of Haemophilus ducreyi infections in the United States. Results of surveillance, 1981–1990. Sex. Transm. Dis. 19(1), 35–38 (1991).
   Google Scholar
• Brunton J, Meier M, Ehrman N, MacLean I, Slaney L, Albritton WL. Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi. Antimicrob. Agents Chemother. 21(6), 857–863 (1982).
   PubMed Web of Science ®Google Scholar
• Roberts MC. Plasmid-mediated Tet M in Haemophilus ducreyi. Antimicrob. Agents Chemother. 33(9), 1611–1613 (1989).
   PubMedGoogle Scholar
• Roberts MC, Actis LA, Crosa JH. Molecular characterization of chloramphenicol-resistant Haemophilus parainfluenzae and Haemophilus ducreyi. Antimicrob. Agents Chemother. 28(2), 176–180 (1985).
   PubMedGoogle Scholar
• Albritton WL, Brunton JL, Slaney L, MacLean I. Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi. Antimicrob. Agents Chemother. 21(1), 159–165 (1982).
   PubMed Web of Science ®Google Scholar
• Moherdaui F, Vuylsteke B, Siqueira LFG et al. Validation of national algorithms for the diagnosis of sexually transmitted diseases in Brazil: results from a multicentre study. Sex. Transm. Infect. 74(Suppl. 1), S38–S43 (1998).
   Google Scholar
• Steen R. Eradicating chancroid. Bull. WHO 79, 818–826 (2001).
   PubMed Web of Science ®Google Scholar
• O’Farrell N. Targeted interventions required against genital ulcers in African countries worst affected by HIV infection. Bull. WHO 79(6), 569–577 (2001).
   PubMed Web of Science ®Google Scholar
• Le Bacq F, Mason PR, Gwanzura L, Robertson VJ, Latif AS. HIV and other sexually transmitted diseases at a rural hospital in Zimbabwe. Genitourinary Med. 69(5), 352–356 (1993).
   PubMedGoogle Scholar
• Beyrer C, Jitwatcharanan K, Natpratan C et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J. Infect. Dis. 178, 243–246 (1998).
   PubMedGoogle Scholar
• Mertz KJ, Trees D, Levine WC et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in ten US cities. The Genital Ulcer Surveillance Group. J. Infect. Dis. 178, 1795–1798 (1998).
   PubMed Web of Science ®Google Scholar
• Roest RW, van der Meijden WI. European guideline for the management of tropical genito-ulcerative diseases. Int. J. STD AIDS 12(Suppl. 3), 78–83 (2001).
   PubMedGoogle Scholar